GPR35 and atherosclerosis: Although GPR35 signaling has been proposed to trigger anti-inflammatory responses in the gut [8,9] and adipose tissue [11], we show that the ablation of GPR35 signaling in bone marrow-derived cells did not influence vascular inflammation and atherosclerosis in hyperlipidemic mice.